Lv2
160 积分 2025-04-07 加入
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial
11小时前
已完结
Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip
1个月前
已完结
Synthesis methods of gold nanoparticles for Localized Surface Plasmon Resonance (LSPR) sensor applications
3个月前
已完结
皖公网安备34019202002308
